Cargando…
OR28-1 Role of Mineralocorticoid Receptor in Metabolic Syndrome
Rates of obesity and metabolic syndrome (MetS) are at epidemic levels, leading to a rise of individuals at higher risk of developing diabetes and heart disease. Increased visceral adiposity and hyperglycemia are two shared features of MetS and excess glucocorticoids (GCs). GCs are hormones—acting pr...
Autores principales: | Ferguson, Daniel, Hutson, Irina, Bauerle, Kevin, Harris, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555001/ http://dx.doi.org/10.1210/js.2019-OR28-1 |
Ejemplares similares
-
Role of Bariatric Surgery in Managing Metabolic Syndrome
por: Iqbal, Iqra, et al.
Publicado: (2021) -
Hyperglycemia-Induced Metabolic Reprogramming Mediates a Proatherogenic Phenotype in Healthy Human Monocytes
por: Castro-Grattoni, Anabel Lourdes, et al.
Publicado: (2021) -
OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019) -
SAT-153 Role Of Increased Serum- And Glucocorticoid-inducible Kinase 1 (SGK1) Activity In Gluconeogenesis And Liver Metabolism During Metabolic Syndrome.
por: Velazquez-Garcia, Silvia, et al.
Publicado: (2019) -
OR28-4 Spontaneous Autoimmune Diabetes in Humanized Mice Carrying Human Type 1 Diabetes Susceptibility
por: Imam, Shahnawaz, et al.
Publicado: (2019)